PharOS Mt Ltd
PolandAll drugs from this manufacturer
-
The medicine is used in the treatment of type 2 diabetes (especially in overweight individuals), in the prevention of type 2 diabetes in patients with prediabetes, and in polycystic ovary syndrome (PCOS).
Dosage form: tablets, prolonged release
Active substance Dosage metformin hydrochloride 500 mg ATC: A10BA02
-
The medicine is used in the treatment of type 2 diabetes (especially in overweight individuals), in the prevention of type 2 diabetes in patients with prediabetes, and in polycystic ovary syndrome (PCOS).
Dosage form: tablets, prolonged release
Active substance Dosage metformin hydrochloride 750 mg ATC: A10BA02
-
The medicine is used in adults who had a heart attack more than a year ago. It helps to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 60 mg ATC: B01AC24
-
The medicine is used in adults who have experienced a heart attack or unstable angina. It helps to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.
Dosage form: tablets, film-coated
Active substance Dosage ticagrelor 90 mg ATC: B01AC24
-
It is used in adults for the treatment of advanced renal cell carcinoma (with metastases to other organs) and in certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib 200 mg ATC: L01EX03
-
The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (with metastases to other organs) and certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib 400 mg ATC: L01EX03
-
The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (including metastatic) and for the treatment of certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 200 mg ATC: L01XE03
-
This medicine is used in adults to treat advanced renal cell carcinoma (including metastatic) and in the treatment of certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 400 mg ATC: L01XE03
-
The medicine is used in adults for the treatment of advanced renal cell carcinoma and for the treatment of certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 200 mg ATC: L01EX03
-
The medicine is used in adults for the treatment of advanced renal cell carcinoma (which has spread to other organs) and for the treatment of certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 400 mg ATC: L01EX03
-
It is used in the treatment of liver cancer and in the treatment of advanced kidney cancer in patients for whom standard therapy has not been effective or is not indicated.
Dosage form: tablets, film-coated
Active substance Dosage sorafenib 200 mg ATC: L01EX02
-
The medicine is used to treat liver cancer and advanced kidney cancer in patients for whom standard therapy has not been effective or was not indicated.
Dosage form: tablets, film-coated
Active substance Dosage sorafenib 200 mg ATC: L01EX02
-
The medicine is used to treat liver cancer, advanced kidney cancer (when standard therapy has not been effective or is not indicated), and thyroid cancer.
Dosage form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg ATC: L01EX02
-
The medicine is intended for adult men with prostate cancer. It is used in cases where the tumor does not respond to hormonal or surgical therapy, when it has spread to other parts of the body, or in men after prostate removal or radiation therapy who experience a rapid increase in PSA levels.
Dosage form: tablets, film-coated
Active substance Dosage enzalutamide 40 mg ATC: L02BB04
-
The medicine is intended for adult men with prostate cancer. It is used when the disease does not respond to hormonal or surgical therapy, when the cancer has spread to other parts of the body, or in men after surgery or radiation who experience a rapid increase in PSA levels.
Dosage form: tablets, film-coated
Active substance Dosage enzalutamide 80 mg ATC: L02BB04
-
The medicine is used to treat type 2 diabetes (in overweight individuals when diet and exercise are insufficient to control blood sugar levels) and in women with polycystic ovary syndrome (PCOS) to stimulate ovulation and increase the chances of pregnancy.
Dosage form: tablets, prolonged release
Active substance Dosage metformin 389.938 mg ATC: A10BA02
-
This medicine is used to treat type 2 diabetes when diet and physical exercise are not sufficient to maintain proper blood sugar levels. It is used especially in overweight individuals. It may also be used in women with polycystic ovary syndrome (PCOS) to stimulate ovulation and increase the chances of pregnancy.
Dosage form: tablets, prolonged release
Active substance Dosage metformin 584.907 mg ATC: A10BA02
-
The medicine is used to treat type 2 diabetes (in overweight patients, when diet and exercise are insufficient to control blood sugar levels) and in women with polycystic ovary syndrome (PCOS) to stimulate ovulation and increase the chances of pregnancy.
Dosage form: tablets, prolonged release
Active substance Dosage metformin hydrochloride 1000 mg ATC: A10BA02